Little is known about why physicians prescribe inappropriate stress ulcer prophylaxis (SUP) among nonintensive care unit (ICU) hospitalized patients without supporting evidence. This study seeks to understand which factors influence physician prescribing behavior regarding SUP.
U
pper gastrointestinal bleeding resulting from stress ulceration is often encountered in critically ill patients, and, as a consequence, stress ulcer prophylaxis (SUP) with either a proton pump inhibitor or a histamine-2 blocker is the standard of care in the intensive care unit (ICU) setting. 1 In 1999, the American Society of Health-System Pharmacists (ASHP) published the only existing guidelines on the use of SUP. 2 The guidelines identify the following risk factors for stress ulcer bleeding: major trauma, severe head injury, multiple organ failure, coagulopathy, prolonged mechanical ventilation, burns covering more than 25-30% of the body, and major surgical procedures.
Despite the fact that SUP is recommended only for selected ICU patients, use of stress ulcer prophylaxis has spread to noncritically ill patients. Multiple studies demonstrate that as many as 25% of hospitalized patients outside of the ICU receive SUP. [3] [4] [5] Moreover, agents prescribed in the hospital for SUP are frequently continued at the time of discharge.
• Inappropriate stress ulcer prophylaxis is a common occurrence among a teaching hospital service, consistent with prior studies.
• Factors such as poor knowledge of appropriate indications and lack of awareness of potential side effects of therapy are associated with inappropriate prescribing.
• Physician education and quality improvement initiatives may be required to decrease inappropriate prescribing of stress ulcer prophylaxis.
In light of these potential complications and lack of accepted indications for SUP in general medical patients, the continued widespread use of SUP remains unexplained. We surveyed hospital-based physicians to identify physician beliefs and other factors that might influence their prescribing of SUP.
Methods
We designed a cross-sectional internet-based survey of physician knowledge and behavior surrounding SUP. The survey was e-mailed to 150 physicians (53 internal medicine residents, 31 internal medicine-pediatrics residents, 19 incoming interns in their first 2 weeks of practice, and 47 hospitalists) from the Baystate Medical Center, a universityaffiliated tertiary care hospital. The anonymous survey was emailed between May 2008 and August 2008. Reminders were sent at 2 week-intervals and participants were personally encouraged to complete the survey. The study was approved by the institutional review board of Baystate Medical Center.
The survey was created by the investigators (Appendix) and pilot-tested for clarity. The introductory paragraph stated that all the questions referred to patients on a general medical ward, not in the ICU. The survey contained 24 questions regarding physicians' background, self-perception of SUP prescribing behavior, familiarity with SUP guidelines, side effects of SUP, and personal prescribing behavior. Demographic questions included place of medical training (United States vs. international) and years of medical experience. To assess knowledge about appropriateness of SUP, we presented 4 patient scenarios and, for each one, asked respondents if SUP was indicated. We then constructed a knowledge score of 0 -4 correct answers, based on the recommendations in the ASHP guideline. 2 Self-reported rate of prescribing SUP in non-ICU patients was the primary outcome. Participants were asked: "When you round on non-ICU hospitalized patients, how often do you prescribe SUP?" Choices included Ͻ25%, 25-49%, 50 -74%, and Ն75%. For purposes of the analysis, respondents were categorized as either low (Ͻ25% of the time) or high (Ն 25% of the time) prescribers.
The data were collected using a web-based interface, SurveyMonkey.com™, (Palo Alto, CA) and analyzed using Stata (StatCorp v. 10.2, College Station, TX). Preliminary analyses were conducted using Fisher's exact test for associations between inappropriate prescribing and categorical variables. Nonparametric tests for trend were used to determine prescribing trends across ordered groups. 18 Clinically relevant bivariable associations were examined in logistic regression to determine whether these associations remained after adjustment for potential confounding factors.
Results
Of 150 physicians who received invitations, 98 physicians (32 hospitalists and 66 residents) completed the survey (response rate 65%). Demographic information is included in Table 1 . Two thirds of the respondents were residents and 44% of them were international medical graduates. Of the 98 respondents, most prescribed less than 50% of the time, while 18% prescribed more than 75% of the time. Both residents and hospitalists reported learning about SUP in medical school (66%), from attending physicians (68%), and in the ICU (60%). Although 79% of the respondents felt that SUP was effective for preventing gastrointestinal bleeding, only 44% of them believed that their opinion was evidence-based. Of the 32% of respondents who reported prescribing SUP according to a guideline, only 5% of those said they used the AHSP guideline, while the remainder identified guidelines that do not exist (eg American College of Physicians). When presented with hypothetical scenarios, most responded that they would prescribe SUP for high risk patients-94% would prescribe SUP for a patient on mechanical ventilation for Ͼ48 hours and 82% for a patient with sepsis and coagulopathy. Many would also prescribe for lower risk patients taking medications generally associated with gastrointestinal bleeding-72% would prescribe SUP for a patient receiving corticosteroid therapy for chronic obstructive pulmonary disease and 46% for a patient taking warfarin for atrial fibrillation.
Less than half of the respondents could correctly identify any potential side effects of proton pump inhibitor therapy ( Fig.) , and 28% of physicians reported having managed a non-ICU patient who was not prescribed SUP and subsequently developed GI bleeding. Physicians were slightly more likely to have been reprimanded by senior colleagues for not prescribing SUP (32%) than for prescribing it (27%). The majority (77%) believed that having esomeprazole as part of our institutional computerized order set makes them more likely to prescribe it, and 18% of respondents reported that they would discharge patients on SUP once started in the hospital.
For purposes of the analysis, SUP prescribing was categorized as high (Ն25% of the time) or low (Ͻ25% of the time; Table 2 ). Sixty-nine percent of physicians were high prescribers. High prescribing behavior was associated with fear of gastrointestinal bleeding (P ϭ 0.04) and of the legal repercussions of not prescribing SUP (P ϭ 0.04), whereas knowledge of SUP indications (P ϭ 0.007) and concern about side effects (P ϭ 0.002) were associated with low prescribing behavior. There was no difference by level of training; in fact, interns in the first 2 weeks of training reported SUP rates similar to those of practicing hospitalists. Although many believed that order sets increased their prescribing, those who held this belief did not have higher prescribing rates than those who did not. Neither belief in the efficacy of SUP, nor receipt of positive or negative reprimands was associated with reported prescribing rates. The four factors identified in bivariable analysis remained significant in multivariable analysis (Table 3) . Considering these factors, high pre- scribing attending physicians were more likely than residents to voice fears of gastrointestinal bleeding (56% vs. 33%, P ϭ 0.29) and legal repercussions (50% vs. 27%, P ϭ 0.07), whereas residents demonstrated less concern for side effects (35% vs. 41%, P ϭ 0.67).
Discussion
In this study of residents and hospitalists at an academic medical center, rate of self-reported prescribing of SUP for general medical patients exceeded 25% but did not differ by level or place of training. High rates of prescribing were linked to fears about bleeding and its legal repercussions, as well as to a lack of concern about side effects and poor knowledge about indications for its use. Most respondents believed SUP was effective, but only 44% of those respondents thought that their belief was evidence-based.
Numerous studies document use of SUP for non-ICU patients. 3, 4, 19 Two cross-sectional studies 5, 20 reported that 20 -25% of general medical patients receive SUP, and rates in our study were even higher, with less than one-third of physicians reporting rates less than 25%. Although the practice is common, little is known about why physicians continue to prescribe SUP in the absence of evidence or specific recommendations. On the contrary, most authors recommend against the use of SUP. [3] [4] [5] 19, 21 Our results suggest several reasons that physicians continue to prescribe SUP for general medicine patients. Firstly, physicians fear that noncritically ill patients who are not on SUP will develop gastrointestinal bleeding. More than a quarter of respondents reported having this experience. However, studies report that such bleeding is rare. In a retrospective case-control study of noncritically ill patients, clinically relevant bleeding occurred in only 0.4% of those studied. 21 Even in the ICU, where SUP is recommended, important bleeding occurs in 3.7% of patients with risk factors but only in 0.1% patients without risk factors. 1, 22 Secondly, physicians prescribe SUP out of fear of legal repercussions in the case of a patient experiencing GI bleeding but not receiving SUP. It is unclear where such beliefs originate, as no physician at our institution has ever been sued for this reason. Interestingly, the internet is full of advertisements encouraging patients who experienced side effects to sue doctors who do prescribe proton pump inhibitors.
Thirdly, physicians were either unaware or unconcerned about the side effects of the agents used for stress ulcer prophylaxis. This is particularly troubling since recent reports have linked SUP agents with increased risk for C difficile colitis, 8, 9 osteoporosis, 10,11 pneumonia, [12] [13] [14] and interstitial nephritis. [15] [16] [17] Finally, physicians were generally unaware of the indications for SUP. Nevertheless, most physicians believed that SUP was effective in general medicine patients. Only two randomized controlled studies 23, 24 have examined the effectiveness of acid suppressive therapy in non-ICU patients. One 24 compared an antacid to placebo and showed a significant reduction in gastrointestinal bleeding in the treatment group. However, although the patients were on general medicine wards, many were severely ill and already had established risk factors for stress ulcer bleeding. Furthermore, the diagnosis of bleeding included occult blood in the stool; only a minority of the patients had clinically significant bleeding. A more recent randomized controlled trial 25 found that SUP did not decrease the incidence of stress related bleeding in high risk/critically ill patients. Finally, a retrospective study 21 of patients admitted to a general medicine ward did not show any benefit of prophylaxis in preventing GI bleeding. A recent consensus statement published after the conclusion of our study recommends outpatient use of PPIs for certain highrisk patients taking aspirin or nonsteroidal anti-inflammatory drugs. 26 However, it does not serve as a guideline for stress ulcer prophylaxis for general medicine inpatients.
Our study has several limitations. First, we studied the responses of physicians within a single hospital, and the results may not be representative of all physicians. However, high rates of SUP in medical patients appear widespread. Second, we cannot know whether the 1/3 of physicians who failed to respond were similar to those who completed the survey. Because this number is small, we do not believe our results have substantial bias. Finally, we relied on self-reported prescribing rates, which may be susceptible to recall bias. Because our goal was to understand physician motivation, in this case, perception may have been as important as reality.
Conclusion
Our study confirms that the use of SUP for general medical patients is widespread and that physicians are generally unaware of the indications for SUP and fears the legal repercussions of not prescribing it. At the same time, they overestimate the risk of stress-induced GI bleeding and underestimate potential harms associated with the use of SUP. At least one practice-based educational intervention at an internal medicine residency program has been shown to reduce inappropriate prescribing of SUP. 27 Thus, individual institutions may wish to develop prescribing protocols, allowing physicians to feel they are providing the standard of care, while at the same time educating them about the indications for SUP. 
